Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy.
Eberle F, Engenhart-Cabillic R, Schymalla MM, Dumke C, Schötz U, Subtil FSB, Baumann KS, Stuck BA, Langer C, Jensen AD, Hauswald H, Lautenschläger S. Eberle F, et al. Among authors: jensen ad. Front Oncol. 2022 Feb 15;12:814082. doi: 10.3389/fonc.2022.814082. eCollection 2022. Front Oncol. 2022. PMID: 35242709 Free PMC article.
COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD, Nikoghosyan AV, Lossner K, Haberer T, Jäkel O, Münter MW, Debus J. Jensen AD, et al. Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):37-46. doi: 10.1016/j.ijrobp.2015.05.013. Epub 2015 May 19. Int J Radiat Oncol Biol Phys. 2015. PMID: 26279022 Clinical Trial.
High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
Mattke M, Vogt K, Bougatf N, Welzel T, Oelmann-Avendano J, Hauswald H, Jensen A, Ellerbrock M, Jäkel O, Haberer T, Herfarth K, Debus J, Uhl M. Mattke M, et al. Cancer. 2018 May 1;124(9):2036-2044. doi: 10.1002/cncr.31298. Epub 2018 Feb 22. Cancer. 2018. PMID: 29469932 Free article.
Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx.
Hauswald H, Jensen AD, Krauss J, Haselmann R, Lossner K, Hartmann S, Windemuth-Kieselbach C, Münter MW, Debus J. Hauswald H, et al. Among authors: jensen ad. Clin Transl Radiat Oncol. 2018 Sep 21;13:64-73. doi: 10.1016/j.ctro.2018.09.005. eCollection 2018 Nov. Clin Transl Radiat Oncol. 2018. PMID: 30370340 Free PMC article.
The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
Adeberg S, Akbaba S, Lang K, Held T, Verma V, Nikoghosyan A, Bernhardt D, Münter M, Freier K, Plinkert P, Hauswald H, Herfarth K, Rieken S, Debus J, Jensen AD. Adeberg S, et al. Among authors: jensen ad. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):167-173. doi: 10.1016/j.ijrobp.2019.09.036. Epub 2019 Oct 3. Int J Radiat Oncol Biol Phys. 2020. PMID: 31586664 Clinical Trial.
Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma.
Eberle F, Lautenschläger S, Engenhart-Cabillic R, Jensen AD, Carl B, Stein M, Debus J, Hauswald H. Eberle F, et al. Among authors: jensen ad. Cancer Manag Res. 2020 Jan 28;12:633-639. doi: 10.2147/CMAR.S217824. eCollection 2020. Cancer Manag Res. 2020. PMID: 32095084 Free PMC article.
154 results